Oxygen Diffusion Capacity and Alveolar-Capillary Transfer

Core Idea

Oxygen diffusion across the alveolar-capillary membrane depends on diffusing capacity (DLCO), which incorporates the alveolar surface area, membrane thickness, and diffusion coefficient of oxygen. Diseases causing alveolar thickening (fibrosis) or surface area loss (emphysema) impair diffusion and cause hypoxemia, particularly during exercise.

Explainer

From your study of gas exchange and diffusion, you know that gases move across membranes according to Fick's law: the rate of diffusion is proportional to the surface area and the partial pressure gradient, and inversely proportional to membrane thickness. The lung is engineered to maximize every term in this equation. The alveolar surface area is enormous — roughly 70 square meters in a healthy adult, about the size of a tennis court — spread across approximately 300 million alveoli. The alveolar-capillary membrane is extraordinarily thin, typically only 0.2 to 0.5 micrometers, consisting of the alveolar epithelium, a fused basement membrane, and the capillary endothelium. And the partial pressure gradient for oxygen is maintained by continuous ventilation (refreshing alveolar air) and perfusion (cycling deoxygenated blood past the membrane).

The lung's diffusing capacity (commonly measured as DLCO using carbon monoxide as a test gas) quantifies how efficiently gas crosses this membrane. DLCO captures both the membrane component (surface area and thickness) and the blood component (the volume of hemoglobin available to bind the gas in pulmonary capillaries). In a healthy resting adult, DLCO is more than sufficient: blood passing through the pulmonary capillaries reaches oxygen equilibrium with alveolar air in about 0.25 seconds, yet the transit time through the capillary bed is roughly 0.75 seconds. This means there is a substantial diffusion reserve — the blood has three times longer than it needs to fully oxygenate.

This reserve becomes critical during exercise. When cardiac output increases, blood moves through the pulmonary capillaries faster, reducing transit time. In a healthy person, even with transit times shortened to 0.25 seconds during heavy exercise, complete equilibration still occurs because the membrane's diffusing capacity is so large. But in disease states, this margin disappears. Pulmonary fibrosis thickens the alveolar-capillary membrane with scar tissue, slowing diffusion so that equilibration requires more time than is available — especially during exercise when transit times are short. Emphysema destroys alveolar walls, dramatically reducing surface area. In either case, the diffusion reserve is consumed, and oxygen levels in arterial blood begin to fall.

This is why exercise-induced hypoxemia is often the earliest clinical sign of diffusion impairment. At rest, even a damaged membrane may allow enough time for adequate oxygenation. But the physiological stress test of exercise exposes the reduced reserve: blood rushes through damaged capillaries too quickly to equilibrate, and arterial oxygen saturation drops. The DLCO measurement captures this vulnerability quantitatively, making it one of the most clinically useful pulmonary function tests for detecting early interstitial lung disease or assessing the severity of emphysema.